Treatment News : A Call to Count More HPV Cancers as AIDS-Defining Illnesses

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » August 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 2, 2013

A Call to Count More HPV Cancers as AIDS-Defining Illnesses

The Western Connecticut Health Network has called for the U.S. Centers for Disease Control and Prevention (CDC) to expand the definition of “AIDS-defining illnesses” to include the full range of human papillomavirus (HPV)–related cancers. At present, the CDC only categorizes cervical cancer as an AIDS-defining illness. Using a recent case report published in Rare Tumors of a 27-year-old HIV-positive woman with advanced vulvar cancer as evidence, the Connecticut group suggests that the CDC should further recognize vulvar, vaginal, penile, anal, lower lid squamous cell carcinoma and some head and neck cancers as AIDS-defining.

“HIV patients with HPV-related cancers other than cervical cancer are not traditionally treated as aggressively as they should be,” Shohreh Shahabi, MD, chair of the Department of Obstetrics, Gynecology and Reproductive Biology at Danbury Hospital and one of the case report authors, said in a release. “Taken together, HIV and HPV-associated cancers create a dangerous combination that requires a new definition of the best standardized treatment.”

The woman in the case report had been on antiretrovirals (ARVs) for a decade when she was diagnosed with cancer, and she had a CD4 count greater than 200, which disqualified her for an AIDS diagnosis. She responded well to radiation and chemotherapy followed by surgery. The paper authors theorize that the woman’s ARV treatment contributed to her ultimate success in responding to the cancer treatment.

To read the case report, click here.

Search: HPV, cancer, AIDS-defining illness, Western Connecticut Health Network, U.S. Centers for Disease Control and Prevention, CDC, Rare Tumors. Shohreh Shahabi, HIV.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (2 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Should the U.S. gay blood ban end?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.